Cholesterol News and Research

RSS

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid.

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

VolitionRx Limited today announced that full results from a completed clinical study of its NuQ blood-based test for early stage pancreatic cancers have been published in the online issue of Clinical Epigenetics, the official journal of the Clinical Epigenetics Society.

14 Oct 2015

Tamoxifen drug clears MRSA, reduces mortality

Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also enhances clearance of the antibiotic-resistant bacterial pathogen MRSA and reduces mortality.

13 Oct 2015

Team-based delivery models can improve quality of care in patients with cardiovascular disease

Patients with coronary artery disease, heart failure, and atrial fibrillation receive comparable outpatient care from physicians and advanced practice providers-- physician assistants and nurse practitioners - although all clinicians fell short in meeting performance measures, according to a study published today in the Journal of the American College of Cardiology.

13 Oct 2015

HDL not so good in protecting women against atherosclerosis, study shows

What has previously been known as good cholesterol--high density lipoprotein (HDL)--has now been shown to be not so good in protecting women against atherosclerosis while they are transitioning through menopause. That's according to a new study from the University of Pittsburgh Graduate School of Public Health that was presented last week at the annual meeting of The North American Menopause Society in Las Vegas.

9 Oct 2015

Repatha (evolocumab) injection gets FDA approval for high cholesterol

The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

9 Oct 2015

Risk of having high blood pressure in adulthood can be detected in childhood

Groups of people at risk of having high blood pressure and other related health issues by age 38 can be identified in childhood, new research from New Zealand's University of Otago suggests.

9 Oct 2015

New research highlights vitamin E needs for people with metabolic syndrome

New research shows that the estimated one-third of Americans who have a cluster of health problems that add up to metabolic syndrome don't absorb dietary vitamin E as effectively as healthy people.

8 Oct 2015

Cardiovascular disease risk can now be predicted for teens

Risk for cardiovascular disease, currently running rampant in the United States, can now be predicted for adolescents thanks to a new diagnostic test developed by a University of Virginia Children's Hospital pediatrician and his collaborators. The test accounts for many risk factors for the deadly disease and has the potential to be adapted by physicians nationwide to assess teenagers' future risk and encourage the healthy behaviors that could save their lives.

7 Oct 2015

General public has limited knowledge of dementia and Alzheimer's Disease

Believing that dementia is a normal part of aging is the most common misconception about dementia, according to a new study conducted by researchers at Trinity College Dublin and St James's Hospital's Dementia Services Centre in Ireland.

7 Oct 2015

Georgia State University researcher receives $1.35 million federal grant to study effects of emulsifiers

Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $1.35 million federal grant to study how emulsifiers affect bacteria in the intestinal tract and cause chronic inflammatory diseases in the gut.

6 Oct 2015

U.S 2nd Annual Obesity Summit: 35 major U.S. health societies see how they can treat obesity

Representatives from 35 major health and medical organizations including, the American Diabetes Association (ADA), American Medical Association (AMA), American Heart Association (AHA), American Academy of Orthopaedic Surgeons (AAOS), and American Society of Clinical Oncology (ASCO) convened for a second annual summit in Chicago to identify opportunities for collaboration in treating obesity. “The National Obesity Summit on the Provision of Care for the Obese Patient” was hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS).

4 Oct 2015

No lasting metabolic health costs from combined GH and GnRH analogue therapy

Gonadotropin-releasing hormone analogue given alongside growth hormone during puberty in order to increase adult height does not have long-term metabolic health consequences in children born small for gestational age, research shows.

1 Oct 2015

OSU researchers develop new approach to treat eczema

Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.

1 Oct 2015

Severely obese children face higher risk of developing heart disease, diabetes

A new study led by researchers in the UNC Department of Pediatrics finds a direct correlation between more severe forms of obesity in children and related risk factors for developing heart disease and diabetes—particularly in boys.

1 Oct 2015

Age, race and family history are the biggest risk factors for prostate cancer, new research suggests

New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and vasectomy also add to the risk. In contrast, obesity, alcohol abuse, and smoking show a negative association with the disease.

30 Sep 2015

New research identifies genetic variants, causal links associated with polycystic ovary syndrome

In the largest genome wide association study (GWAS) into polycystic ovary syndrome (PCOS) to date, new research conducted by scientists at the University of Cambridge and ten other institutions, including 23andMe, has identified genetic variants and causal links associated with PCOS, some of which might be relevant to informing positive lifestyle and treatment choices for women.

30 Sep 2015

UAB awarded $9.4 million grant to lead a trial to improve blood pressure in the U.S Black Belt

The University of Alabama at Birmingham has been awarded a $9.4 million grant to lead a trial in an effort to improve blood pressure in the Black Belt of the United States.

29 Sep 2015

The Center for Bariatric Surgery receives MBSAQIP accreditation for safe, high-quality bariatric patient care

The Center for Bariatric Surgery has earned certification for adult and teen weight loss surgery under the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) which sets standards for safe, high-quality bariatric patient care.

29 Sep 2015

Bariatric surgery results in substantial weight loss in overweight children with Prader-Willi syndrome

Obesity is a leading cause of complications and death in children suffering from Prader-Willi syndrome (PWS), yet there are few effective treatment options for these patients. In a new study published in Surgery for Obesity and Related Disease researchers found that bariatric surgery, specifically laparoscopic sleeve gastrectomy (LSG), resulted in substantial weight loss with no apparent adverse effect on growth in a small group of severely overweight patients with PWS.

29 Sep 2015

UT Southwestern Medical Center geneticist named 2015 recipient of Pearl Meister Greengard Prize

UT Southwestern Medical Center geneticist Dr. Helen Hobbs is the 2015 recipient of the prestigious Pearl Meister Greengard Prize. The prize recognizes Dr. Hobbs' research, which advances understanding of heart disease and other complex disorders.

29 Sep 2015

Cholesterol News and Research

Further Reading

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

Tamoxifen drug clears MRSA, reduces mortality

Team-based delivery models can improve quality of care in patients with cardiovascular disease

HDL not so good in protecting women against atherosclerosis, study shows

Repatha (evolocumab) injection gets FDA approval for high cholesterol

Risk of having high blood pressure in adulthood can be detected in childhood

New research highlights vitamin E needs for people with metabolic syndrome

Cardiovascular disease risk can now be predicted for teens

General public has limited knowledge of dementia and Alzheimer's Disease

Georgia State University researcher receives $1.35 million federal grant to study effects of emulsifiers

U.S 2nd Annual Obesity Summit: 35 major U.S. health societies see how they can treat obesity

No lasting metabolic health costs from combined GH and GnRH analogue therapy

OSU researchers develop new approach to treat eczema

Severely obese children face higher risk of developing heart disease, diabetes

Age, race and family history are the biggest risk factors for prostate cancer, new research suggests

New research identifies genetic variants, causal links associated with polycystic ovary syndrome

UAB awarded $9.4 million grant to lead a trial to improve blood pressure in the U.S Black Belt

The Center for Bariatric Surgery receives MBSAQIP accreditation for safe, high-quality bariatric patient care

Bariatric surgery results in substantial weight loss in overweight children with Prader-Willi syndrome

UT Southwestern Medical Center geneticist named 2015 recipient of Pearl Meister Greengard Prize

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News